Preparation method and application of anti-blue light film based on TB-thiophene malononitrile derivative

By synthesizing TB-thiophene malononitrile derivatives and doping them into PVA films, a highly efficient anti-blue light film was prepared, which solved the problems of low shielding efficiency and high cost of existing anti-blue light films for short-wavelength blue light, and achieved the effect of highly efficient protection of ARPE-19 cells and reduced cost.

CN116769205BActive Publication Date: 2026-11-17XUZHOU NORMAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202310914231.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-07-25
Publication Date
2026-11-17
Estimated Expiration
2043-07-25

AI Technical Summary

Technical Problem

Existing blue light blocking film materials are not highly targeted at short-wavelength blue light, have complex manufacturing processes, are costly, and may cause harm to non-wearers. Commercially available blue light blocking films have insufficient blue light shielding rates and cannot effectively protect human eyes.

Method used

Using TB-thiophene malononitrile derivatives as blue light absorbing materials, a TB-thiophene malononitrile derivative anti-blue light film was prepared by synthesizing and doping it into a PVA film through a multi-step reaction. This film is used to block blue light and protect ARPE-19 cells.

Benefits of technology

It achieves highly efficient blue light shielding, increasing the blue light blocking rate to 99.4%, reducing damage to ARPE-19 cells, and is low in toxicity and low in cost, suitable for human physiological environments, and has good light transmittance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116769205B_ABST
    Figure CN116769205B_ABST
Patent Text Reader

Abstract

This invention provides a method for preparing and applying anti-blue light films based on TB-thiophene malononitrile derivatives. Using p-bromoaniline, 4-bromo-3-methoxyaniline, paraformaldehyde, n-butyllithium, 5-bromothiophene-2-carboxaldehyde, and malononitrile as raw materials, a multi-step reaction is performed to synthesize the following: The first derivative (9), the second derivative (10), the fifth intermediate (11), or the third derivative (12) are doped into polyvinyl alcohol (PVA) to obtain corresponding films PVA-9, PVA-10, PVA-11, and PVA-12. These films are mainly used for shielding blue light and protecting human retinal pigment epithelial cells (ARPE-19). The prepared pure organic small-molecule anti-blue light films based on TB-thiophene malononitrile derivatives exhibit high blue light blocking rate, high visible light transmittance, high ARPE-19 cell protection ability, and low toxicity, showing great development potential.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of chemical synthesis, specifically involving Synthesis of base (TB)-thiophene malononitrile derivatives; doping Preparation of PVA films based on thiophene malononitrile derivatives and their applications in blue light blocking, visible light transmission, and ARPE-19 cell protection. Background Technology

[0002] Blue light is visible light with wavelengths between 400-500 nm. It has the shortest wavelength and highest energy in the visible light spectrum and is often referred to as high-energy visible light. The most harmful blue light to the human body is high-energy short-wavelength blue light with irregular frequencies in the 415-455 nm range, which is most destructive to retinal pigment epithelial cells (RPE cells). It can directly penetrate the lens and reach the retina, causing the retina to produce free radicals, leading to the death of retinal pigment epithelial cells. Simultaneously, it deprives photoreceptor cells of nutrients, causing vision impairment, macular degeneration, compression of the lens, damage to RPE cells, and even their death.

[0003] In daily life, the main sources of blue light are electronic products such as digital screens (e.g., mobile phones, computers, and televisions), light-emitting diodes (LEDs), and fluorescent lamps. With the continuous upgrading of electronic products, more and more electronic products are entering households, greatly increasing the chances of people being exposed to blue light radiation. Prolonged use of electronic products such as mobile phones, iPads, computers, and televisions without anti-blue light protection can lead to symptoms such as eye strain, eye fatigue, tearing, blurred vision, and photophobia, and in severe cases, it can cause myopia, vision loss or even blindness, retinal deformities, macular degeneration, and other eye diseases.

[0004] Currently, the most important and traditional method for reducing blue light damage to the retina is the use of blue light blocking films (divided into reflective and absorptive types). Reflective blue light blocking films are made by depositing or coating multiple layers onto the surface of an object. By adjusting the material, refractive index, and thickness of each layer, they repeatedly reflect and block incident blue light of a specified wavelength, thereby reducing blue light transmittance and achieving a blue light blocking effect. These films mostly use inorganic materials such as TiO2, SiO2, Ho2O3, and CeO2. However, they require high uniformity, are costly, and demand a high level of expertise from the users. More importantly, while these films provide excellent blue light blocking for the wearer, they can potentially harm those not wearing the film. Therefore, recent research on blue light blocking films has largely focused on absorptive types.

[0005] Absorbent blue light blocking films are thin films with blue light absorption capabilities, prepared using inorganic, organic, or inorganic-organic mixed materials as blue light absorbers and doped with certain polymers (such as PVA, cellulose gel, polyurethane, etc.). Compared to reflective blue light blocking films, absorptive blue light blocking films do not affect non-wearers, thus having greater application value and development prospects. Currently, most commercially available or reported absorptive blue light blocking films use Al2O3, TiO2, Fe2O3, benzotriazoles, isoindolineones, fullerenes, etc., as raw materials. However, these films are not highly targeted at short-wavelength blue light, have complex manufacturing processes, and a wide absorption range. Moreover, since research on blue light blocking films in my country is still in its early stages, the average blue light shielding rate of currently commercially available blue light blocking films is only 36%, far from meeting the requirements in various aspects, indicating a very large research and market potential.

[0006] Therefore, developing blue light absorbing materials that are simple to prepare, low in cost, and specifically target short-wavelength blue light to reduce the harm of blue light to the human eye is of great research value.

[0007] TB and its derivatives have a unique V-shaped framework and a long conjugated structure. Under photon excitation, they exhibit multiple transition modes (π-π*, n-π*, and spatial transitions), and theoretically have a large molar absorption coefficient, making them an excellent basic framework for blue light absorbing materials.

[0008] Thiophene is a special sulfur-containing five-membered heterocyclic ring. Thiophene and its derivatives are important heterocyclic compounds with a variety of properties and uses. They are used as corrosion inhibitors in industrial chemistry and materials science; they play an important role in the development of organic semiconductors, organic field-effect transistors (OFETs), and the manufacture of organic light-emitting diodes (OLEDs); at the same time, they also have many pharmacological properties, such as anti-inflammatory, antibacterial, and anti-atherosclerotic effects.

[0009] Malononitrile contains two strong electron-withdrawing groups and a reactive methylene group, exhibiting excellent photostability and serving as an important synthon for many types of compounds. The structure of malononitrile is easily modified, which is crucial for adjusting the molecular absorption wavelength, improving the selective absorption of blue light, or increasing the transmittance of the molecule in the visible light region.

[0010] Therefore, the D-π-A structure formed by introducing thiophene and malononitrile into TB can create a smooth environment for electron flow, thereby increasing the probability of electron transition and increasing its light absorption intensity and efficiency.

[0011] Therefore, this invention introduces thiophene and malononitrile into the TB framework to synthesize two TB-malononitrile derivatives. The optical properties of the products were tested and they were used for blue light blocking, exploring their application as blue light absorbing materials. Summary of the Invention

[0012] Technical Problem: The purpose of this invention is to provide a method for preparing and applying an anti-blue light film based on TB-thiophene malononitrile derivatives. The method uses p-bromoaniline, 4-bromo-3-methoxyaniline, paraformaldehyde, n-butyllithium, 5-bromothiophene-2-carboxaldehyde, malononitrile, etc., as raw materials, and synthesizes a type of anti-blue light film through multiple reaction steps. The base-thiophene malononitrile derivative was doped into PVA to prepare the corresponding PVA film, and it was applied to blue light blocking, visible light transmission, ARPE-19 cell protection and other applications.

[0013] Technical solution: The present invention provides a method for preparing an anti-blue light film based on a TB-thiophene malononitrile derivative, comprising:

[0014] Step 1: 4-Bromoaniline 1 or 2-methoxy-4-bromoaniline 4 reacts with paraformaldehyde 2 to obtain the first intermediate 3 or the second intermediate 5, as shown in the following reaction formula:

[0015]

[0016]

[0017] Step 2: The first intermediate 3 or the second intermediate 5 reacts with n-butyllithium to obtain the third intermediate 6 or the fourth intermediate 7, as shown in the following reaction formula:

[0018]

[0019] Step 3: The third intermediate 6 or the fourth intermediate 7 reacts with 5-bromothiophene-2-carboxaldehyde 8 to obtain the first derivative 9 or the second derivative 10, as shown in the following reaction formula:

[0020]

[0021] Step 4: The first derivative 9 or the second derivative 10 reacts with malononitrile to obtain the fifth intermediate 11 or the third derivative 12, as shown in the following reaction formula:

[0022]

[0023] The first derivative 9, the second derivative 10, the third derivative 12, or the fifth intermediate 11 are doped into polyvinyl alcohol (PVA) to prepare the corresponding films PVA-9, PVA-10, PVA-11, and PVA-12.

[0024] The polyvinyl alcohol (PVA) has a relative molecular mass MW = 3000 g / mol.

[0025] The prepared PVA films include three types: PVA-9 (0.1 wt%, 0.5 wt%, and 1.0 wt%), PVA-10 (0.1 wt%, 0.5 wt%, and 1.0 wt%), PVA-11 (0.1 wt%, 0.5 wt%, and 1.0 wt%), and PVA-12 (0.1 wt%, 0.5 wt%, and 1.0 wt%).

[0026] The application of the anti-blue light film based on TB-thiophene malononitrile derivative prepared by the method of the present invention, and the application of the films PVA-9, PVA-10, PVA-11, and PVA-12 in shielding blue light.

[0027] The application of the anti-blue light film based on TB-thiophene malononitrile derivative prepared by the method of the present invention, and the application of the films PVA-9, PVA-10, PVA-11, and PVA-12 in terms of visible light transmission.

[0028] The application of the anti-blue light film based on TB-thiophene malononitrile derivative prepared by the method of the present invention, and the application of the films PVA-9, PVA-10, PVA-11, and PVA-12 in protecting human retinal pigment epithelial cells ARPE-19.

[0029] Beneficial effects:

[0030] 1. First synthesis Base-thiophene malononitrile-based blue light absorbing materials have simple synthesis methods and convenient post-processing.

[0031] 2. The product has a wide pH range and can be used in human physiological environments.

[0032] 3. The product exhibits very low dark toxicity and phototoxicity to normal human liver immortalized cells (THLE-2).

[0033] 4. The prepared anti-blue light film is a pure organic small molecule flexible film, which can avoid the disadvantages of inorganic materials such as non-renewable, non-modifiable, and non-foldable. Moreover, it is easier to control the designability and adjustability of the molecular structure.

[0034] 5. The prepared anti-blue light film has a high blue light blocking rate. For example, the blocking rate of PVA-11 (99.4%) at a lower content (1.0wt%) is higher than the literature value (e.g., the blue light blocking rate of 40wt% CdS film is 98%), which is far higher than the average blue light blocking rate of 36% of commercially available anti-blue light films.

[0035] 6. The prepared anti-blue light film has high visible light transmittance (the visible light transmittance of PVA-11 and PVA-12 is 82.3% and 74.0%, respectively).

[0036] 7. The prepared anti-blue light films PVA-11 and PVA-12 can reduce the damage of blue light (452nm) to ARPE-19 cells from 55.8% to 14.3% and 34.3%, respectively, which can greatly reduce the damage of blue light to ARPE-19 cells. They have high ARPE-19 cell protection ability and low toxicity, and have great development value.

[0037] 8. Compared with commercially available anti-blue light films, the anti-blue light film produced has a lower cost. Attached Figure Description

[0038] Figure 1 The following are the UV absorption and fluorescence emission spectra of the first derivative 9 in different solvents in the examples: (a) UV absorption and (b) fluorescence emission spectra of the second derivative 10 in different solvents; (c) UV absorption and (d) fluorescence emission spectra of the fifth intermediate 11 in different solvents; and (e) UV absorption and (f) fluorescence emission spectra of the third derivative 12 in different solvents.

[0039] Figure 2 These are the solid-state fluorescence emission spectra of the first derivative 9, the second derivative 10, the third derivative 12, and the fifth intermediate 11 in the embodiments;

[0040] Figure 3 The fluorescence emission spectra and line graphs of compounds (a) first derivative 9, (b) second derivative 10, (c) fifth intermediate 11, and (d) third derivative 12 in the examples are shown at different pH values.

[0041] Figure 4 These are photographs of films prepared in the examples with different contents (from left to right: 0.0wt%, 0.1wt%, 0.5wt%, 1.0wt%): (a) PVA-9, (b) PVA-10, (c) PVA-11, and (d) PVA-12.

[0042] Figure 5 These are photographs of PVA-9 to PVA-12 films with different contents (from left to right: 0.1wt%, 0.5wt%, 1.0wt%) covered with the word "JSNU" prepared in the examples;

[0043] Figure 6 The transmission spectra of PVA-9(a), PVA-10(b), PVA-9(c), and PVA-12(d) films with different contents prepared in the examples are shown.

[0044] Figure 7This is the transmission spectrum of a commercially available anti-blue film;

[0045] Figure 8 The fluorescence emission spectra and line graphs of the 1.0 wt% PVA-9(a), PVA-10(b), PVA-9(c), and PVA-12(d) films prepared in the examples at different pH values ​​are shown.

[0046] Figure 9 The fluorescence emission spectra and line graphs of the 1.0 wt% PVA-9(a), PVA-10(b), PVA-9(c), and PVA-12(d) films prepared in the examples in different solvents are shown.

[0047] Figure 10 These are images showing the blocking effects of the thin films prepared in the examples on a blue LED (450nm): (a) blank, (b) pure PVA (0.0wt%), (c) PVA-9 (1.0wt%), (d) PVA-10 (1.0wt%), (e) PVA-11 (1.0wt%), and (f) PVA-12 (1.0wt%).

[0048] Figure 11 The protective effect of the 1.0 wt% film prepared in the examples on ARPE-19 cells (survival rate after 4 hours of incubation under different conditions);

[0049] Figure 12 The morphology of ARPE-19 cells in (a) darkness; (b) blue light; (c) PVA-21 in the covered example; and (d) PVA-22 in the covered example.

[0050] Figure 13 The survival rate of THLE-2 cells after incubation with different concentrations of compounds 9(a), 10(b), (c), and (d) in the examples under dark conditions or light for 48 hours is shown.

[0051] Figure 14 It is the first derivative 9 in the embodiment. 1 H NMR spectrum;

[0052] Figure 15 This is the HRMS spectrum of the first derivative 9 in the embodiment;

[0053] Figure 16 It is the second derivative 10 in the embodiment. 1 H NMR spectrum;

[0054] Figure 17 This is the HRMS spectrum of the second derivative 10 in the embodiment.

[0055] Figure 18It is the third derivative 12 in the embodiment. 1 H NMR spectrum;

[0056] Figure 19 It is the third derivative 12 in the embodiment. 13 C NMR spectrum;

[0057] Figure 20 This is the HRMS spectrum of the third derivative 12 in the embodiment. Detailed Implementation

[0058] Table 1. Structural formulas of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11

[0059]

[0060] The embodiments of the present invention are described in detail below. The embodiments described below are exemplary and are only used to explain the present invention, and should not be construed as limiting the present invention. Those skilled in the art will understand that various changes and modifications can be made to the present invention without departing from the spirit and scope thereof.

[0061] The structural formulas of base-thiophene malononitrile derivatives are shown in Table 1.

[0062] Example 1: Synthesis of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11. This invention provides the above-mentioned novel sulfonamide-naphthalimide- Methods for preparing base derivatives include:

[0063] In this embodiment, p-bromoaniline, 4-bromo-3-methoxyaniline, paraformaldehyde, 5-bromothiophene-2-carboxaldehyde, malononitrile, etc., were used as raw materials to synthesize the product through a multi-step reaction process. The base-thiophene malononitrile derivative comprises the following steps:

[0064] 1. Synthesis of the first intermediate 3

[0065] Weigh 10.32 g (60 mmol) of p-bromoaniline and 4.5 g (150 mmol) of paraformaldehyde into a 250 mL round-bottom flask, cool to -15 °C, and slowly add 120 mL of trifluoroacetic acid dropwise through a constant-pressure dropping funnel. After the addition is complete, move the reaction system to room temperature and react for seven days. Quench with ice water, adjust the pH to neutral with ammonia, extract with ethyl acetate, extract the organic phase again with saturated brine, dry with anhydrous sodium sulfate, and purify by column chromatography (V). 石油醚 :V 乙酸乙酯 =2:1), and finally recrystallized with acetone, dried, weighed and collected to obtain the first intermediate 3 (yield 73%).

[0066]

[0067] 2. Synthesis of the second intermediate 5

[0068] Weigh 11.16 g (60 mmol) of 4-bromo-3-methoxyaniline 4 and 4.5 g (150 mmol) of paraformaldehyde into a 250 mL round-bottom flask and cool to -15 °C. Slowly add 120 mL of trifluoroacetic acid dropwise through a constant-pressure dropping funnel. After the addition is complete, move the reaction system to room temperature and react for seven days. Quench with ice water and adjust the pH to neutral with ammonia. A large amount of precipitate is produced. Filter, dry, weigh, and collect to obtain the second intermediate 5 (yield 68%).

[0069]

[0070] 3. Synthesis of the third intermediate 6

[0071] Weigh 3 (1 mmol) into a 100 mL round-bottom flask, use anhydrous tetrahydrofuran (50 mL) as solvent, place in a -78 °C cryogenic bath under anhydrous and oxygen-free conditions, slowly add 9.6 mL of n-butyllithium, after 2 h, quickly add 6.6 mL of trimethyl borate, after 1 h, quench with 100 mL of ice water, extract with DCM, acidify the aqueous layer with HCl, filter, and obtain the third intermediate 6 (yield 63%).

[0072]

[0073] 4. Synthesis of the fourth intermediate 7

[0074] Weigh 5 (1 mmol) into a 100 mL round-bottom flask, use anhydrous tetrahydrofuran (50 mL) as solvent, place in a -78 °C cryogenic bath under anhydrous and oxygen-free conditions, slowly add 5 mL n-butyllithium, after 2 h, quickly add 5 mL trimethyl borate, after 1 h, quench with 100 mL ice water, extract with DCM, acidify the aqueous layer with HCl, filter, and obtain the fourth intermediate 7 (yield 53%).

[0075]

[0076] 5. Synthesis of the first derivative 9

[0077] Compounds 6 (1.0 mmol), 8 (1.2 mmol), tetrakis(triphenylphosphine)palladium (0.2 mmol), and K₂CO₃ (0.2 mmol) were weighed and added to a 100 mL round-bottom flask. Under argon protection, 20 mL of anhydrous toluene was added, and the reaction was carried out at 90 °C for 24 h. After the reaction was complete (TLC monitoring), the mixture was quenched with water, extracted with ethyl acetate (10.0 mL × 3), dried over Na₂SO₄, and the crude product obtained by rotary evaporation was purified by column chromatography (V). 石油醚:V 乙酸乙酯 =4:1), yielding the first derivative 9 (yield 63%).

[0078]

[0079] 6. Synthesis of the second derivative 10

[0080] Compounds 7 (1.0 mmol), 8 (1.2 mmol), tetrakis(triphenylphosphine)palladium (0.2 mmol), and K₂CO₃ (0.2 mmol) were weighed and added to a 100 mL round-bottom flask. Under argon protection, 20 mL of anhydrous toluene was added, and the reaction was carried out at 90 °C for 24 h. After the reaction was complete (TLC monitoring), the mixture was quenched with water, extracted with ethyl acetate (10.0 mL × 3), dried over Na₂SO₄, and the crude product obtained by rotary evaporation was purified by column chromatography (V). 石油醚 :V 乙酸乙酯 =4:1), yielding the second derivative 10 (yield 72%).

[0081]

[0082] 7. Synthesis of the fifth intermediate 11

[0083] Compound 9 (1.0 mmol), malononitrile (1.2 mmol), and 10.0 mL of anhydrous ethanol were weighed and added sequentially to a 100 mL round-bottom flask. The reaction was carried out at 70 °C for 6 h under argon protection. After the reaction was complete (TLC monitoring), the mixture was quenched with water, extracted with ethyl acetate (10.0 mL × 3), and the crude product after drying the organic phase with Na₂SO₄ was purified by column chromatography (V). 石油醚 :V 乙酸乙酯 =2:1), yielding the fifth intermediate 11 (yield 71%):

[0084]

[0085] The molecular formula of the fifth intermediate 11 is: C 23 H 17 BN4O2S

[0086] The Chinese name is: (8-(5-(2,2-dicyanovinyl)thiophen-2-yl)-6H,12H-5,11-methyldibenzo[b,f][1,5]diazoindene-2-yl)boronic acid

[0087] The English name is:

[0088] (8-(5-(2,2-dicyanovinyl)thiophen-2-yl)-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocin-2-yl)boronic acid

[0089] Appearance: Red solid

[0090] Melting point: 184.2-184.8℃

[0091] 1H NMR spectrum: 1 H NMR (400MHz, CDCl3) δ7.73(s,1H),7.64(d,J=4.0Hz,1H),7.49(d,J=8.1Hz,1H,Ar-H),7.39-7.38(m,1H,-OH),7.30(d,J=4.0Hz,1H),7.24(s,1H,-OH ),7.21-7.15(m,3H,Ar-H),7.00(d,J=7.2Hz,1H,Ar-H),6.93(d,J=7.5Hz,1H,Ar-H),4.76-4.72(m,2H,-CH2-bridge),4.38-4.20(m,4H,TB-CH2*2);

[0092] Carbon NMR spectrum: 13 C NMR (100MHz, DMSO-d6) δ155.06,144.55,131.35,120.50,109.10,107.78,66.06,56.83,56.63,40.49,40.28,40.07,39.96,39.65,39.44,39.23.

[0093] Mass spectrometry: HRMS(ESI) m / z calcd for C 23 H 17 BN4O2S[M+H] + :425.1242; found,425.1268.

[0094] 8. Synthesis of the third derivative 12

[0095] Compound 10 (1.0 mmol), malononitrile (1.2 mmol), and 10.0 mL of anhydrous ethanol were weighed and added sequentially to a 100 mL round-bottom flask. The reaction was carried out at 70 °C for 6 h under argon protection. After the reaction was complete (TLC monitoring), the mixture was quenched with water, extracted with ethyl acetate (10.0 mL × 3), and the crude product after drying the organic phase with Na₂SO₄ was purified by column chromatography (V). PE :V EA =2:1), yielding the third derivative 12 (yield 74%).

[0096]

[0097] The molecular formula of the third derivative 12 is: C 25H 21 BN4O4S

[0098] The Chinese name is: (8-(5-(2,2-dicyanovinyl)thiophen-2-yl)-3,9-dimethoxy-6H,12H-5,11-methyldibenzo[b,f][1,5]diazoazine-2-yl)boronic acid

[0099] The English name is:

[0100] (8-(5-(2,2-dicyanovinyl)thiophen-2-yl)-3,9-dimethoxy-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocin-2-yl)boronic acid

[0101] Appearance: Red solid

[0102] Melting point: 109.7-110.1℃

[0103] 1H NMR spectrum: 1 H NMR (400MHz, CDCl3) δ7.78(s,1H),7.74(d,J=4.0Hz,1H),7.58(d,J=4.1Hz,1H),7.33(s,1H),7.15(s,1H),6.81(s,1 H),6.75(d,J=10.1Hz,1H),4.78-4.68(m,2H),4.34(d,J=13.5Hz,2H),4.30-4.20(m,2H),4.01(s,3H),3.92(s,3H).

[0104] Carbon NMR spectrum: 13 C NMR (100MHz, CDCl3-d6)159.21,155.96,152.20,151.51,150.69,134.08,132.24,132.14,128.67,128.55,127.74,1 26.96,125.91,120.66,119.51,117.89,114.77,113.91,111.52,109.46,107.90,75.06,66.82,58.13,55.88,55.40.

[0105] Mass spectrometry: HRMS(ESI) m / z calcd for C 25 H 21 BN4O4S[M+H] + :485.145; found,485.1466.

[0106] Example 2: Solvation effect of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11

[0107] Derivative 9, derivative 10, derivative 12, and intermediate 11 were respectively prepared into a concentration of 1×10⁻⁶ using 100 mL of N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), n-hexane, dichloromethane (CH₂Cl₂), toluene, tetrahydrofuran (THF), methanol, acetonitrile, and distilled water. -5 mol·L -1 The solution was analyzed, and its ultraviolet absorption and fluorescence emission spectra were measured. The optimal test solvent for subsequent experiments was selected by comprehensively considering factors such as solubility, absorbance, absorption wavelength, and luminescence properties. Figure 1 ).

[0108] The optical properties of the first derivative 9, the second derivative 10, the third derivative 12 and the fifth intermediate 11 were tested using THF, which has high absorbance in the blue light region, as a solvent.

[0109] Example 3: Solid-state fluorescence spectra of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11

[0110] The first derivative 9, the second derivative 10, the third derivative 12, and the fifth intermediate 11 were respectively laid flat and pressed into tablets, and their solid-state fluorescence emission spectra were measured. Figure 2 ).Depend on Figure 2 It can be seen that the first derivative 9, the second derivative 10, the third derivative 12 and the fifth intermediate 11 all have stable solid-state fluorescence emission, indicating that they can be doped into PVA films to determine their luminescence properties.

[0111] The spectral data of the products are shown in Table 2:

[0112] Table 2. Spectral data of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11

[0113]

[0114]

[0115] a Ultraviolet absorption wavelength in solution; b The molar extinction coefficient ε = A / bC, with units of L·mol⁻¹ -1 ·cm -1 ; c Fluorescence emission wavelength in solution; dStokes displacement in solution; e Relative fluorescence quantum yield (reference: quinine sulfate); f Fluorescence intensity FB = ε*Φ, unit is L·mol -1 ·cm -1 ; g Solid-state excitation wavelength; h Solid-state fluorescence emission wavelength; i Solid-state Stokes displacement; j Lipid-water partition coefficient (ChemBioDraw Ultra simulation).

[0116] Depend on Figure 2 As shown in Table 2, the λ values ​​of the first derivative 9 and the second derivative 10 are... abs The λ values ​​for the fifth intermediate 11 and the third derivative 12 after the introduction of malononitrile are 357 and 365 nm, respectively. abs The wavelengths are 428 and 447 nm, which are within the blue light region (415-455 nm) that is most harmful to the human body. Compared with the first derivative 9 and the second derivative 10, the RFI of the fifth intermediate 11 and the third derivative 12 is reduced. This may be because the introduction of malononitrile increases the probability of ISC, thereby causing a decrease in the probability of fluorescence emission.

[0117] Example 4: pH range of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11

[0118] pH range is one of the key factors for the successful application of a compound in biological systems, so we explored the pH range of product 9-12.

[0119] The first derivative 9, the second derivative 10, the third derivative 12, and the fifth intermediate 11 were prepared into solutions with a concentration of 1×10⁻⁶ using THF as a solvent. -4 mol·L -1 For each working solution, measure 1.0 mL of the working solution into a 10 mL volumetric flask, then add 1.0 mL of buffer solution with pH values ​​of 2.2-10 (citric acid / disodium hydrogen phosphate system for pH 2.2-8, and sodium bicarbonate / sodium carbonate system for pH 9-10), and dilute to volume with THF to a concentration of 1×10⁻⁶. -5 mol·L -1 Measure its fluorescence emission spectrum ( Figure 3 ).

[0120] Depend on Figure 3 It can be seen that when the solution pH is 7-10, the fluorescence emission spectra of the first derivative 9, the second derivative 10, the third derivative 12 and the fifth intermediate 11 do not change significantly, indicating that they have a wide pH range and can be used in human physiological environments.

[0121] Example 5: Properties of the PVA films of the present invention

[0122] 1.0 g of polyvinyl alcohol (PVA, MW = 3000 g / mol) powder was dissolved in 20 mL of deionized water and stirred vigorously at 90 °C until the solution became clear. The solution was then cooled to room temperature. Derivatives 9, 10, 12, and 11 (0.1, 0.5, and 1.0 wt%) were added to the PVA solution, and the mixtures were stirred for 1 hour to obtain homogeneous solutions. The solutions were then transferred to petri dishes using pipettes and dried at 90 °C for 1 day. Different concentrations of PVA-9, PVA-10, PVA-11, and PVA-12 (0.1, 0.5, and 1.0 wt%) were obtained. Figure 4 ).

[0123] The prepared films PVA-9, PVA-10, PVA-11, and PVA-12 were uniform and highly transparent. With increasing content of the first derivative 9, the second derivative 10, the third derivative 12, and the fifth intermediate 11, the corresponding films darkened in color but still maintained high transparency. When observing the letters "JSNU" through PVA-9, PVA-10, PVA-11, and PVA-12, the color was not affected by the compounds themselves. Figure 5 ).

[0124] PVA films with different loadings all exhibit high transparency comparable to pure PVA films and can be used in subsequent experiments.

[0125] Example 6: Selection of PVA film loading in this invention

[0126] The transmittance of PVA-9, PVA-10, PVA-11, and PVA-12 was measured using a UV-Vis spectrophotometer. Figure 6 ).

[0127] Depend on Figure 6 (c, d) It can be seen that pure PVA films have no absorption in the blue light region. PVA-11 and PVA-12 (0.1wt%, 0.5wt%, and 1.0wt%) have low transmittance of blue light in the 400-500nm range, indicating their excellent blue light blocking ability. Furthermore, the blue light transmittance decreases sharply with increasing content of intermediate 11 and derivative 12. Calculations show that when the content is 1.0wt%, the blue light blocking rates of intermediate 11 and derivative 12 reach 99.37% and 90.23%, respectively. Even with a PVA-11 loading far lower than the literature value (40wt% CdS), its blue light blocking rate is higher than the literature value of 98%.

[0128] The transmittance of PVA-11 and PVA-12 (0.1wt%, 0.5wt%, and 1.0wt%) in the visible light region of 500-800 nm was studied. Figure 6 With increasing content of intermediate 11 and derivative 12, the transmittance of PVA-11 and PVA-12 films in the visible light range decreased slightly, but still remained close to 70%. When the content of intermediate 11 and derivative 12 was 1.0 wt%, their transmittance to visible light was 82.30% and 74.02%, respectively.

[0129] Therefore, taking into account both the blue light blocking rate and the visible light transmittance, 1.0 wt% was selected as the optimal loading for PVA-11 and PVA-12 films.

[0130] like Figure 7 It has been found that commercially available blue light blocking films that claim to block 99.0% of blue light actually only block 36.0% after testing.

[0131] Example 7: Stability of various PVA films of the present invention

[0132] PVA-9, PVA-10, PVA-11, and PVA-12 were soaked for 12 hours at pH values ​​ranging from 2.2 to 14.0, then air-dried. Acid and alkali resistance tests were then conducted, and their fluorescence emission spectra were measured. Figure 8 It can be seen that PVA-9, PVA-10, PVA-11, and PVA-12 can maintain their fluorescence intensity after being soaked for 12 hours under conditions of pH 2.2-14.0, indicating that PVA-9, PVA-10, PVA-11, and PVA-12 have high stability under both acidic and alkaline conditions.

[0133] PVA-9, PVA-10, PVA-11, and PVA-12 were immersed in different solvents for 24 hours, then air-dried, and solvent resistance tests were conducted to measure their fluorescence emission spectra. For example... Figure 9 As shown, PVA-9, PVA-10, PVA-11, and PVA-12 can still maintain their fluorescence intensity after being immersed in different solvents for 24 hours, indicating that PVA-9, PVA-10, PVA-11, and PVA-12 have good solvent resistance.

[0134] Example 8: Blue light shielding capability of various PVA films of the present invention

[0135] The blue light blocking performance of PVA-9, PVA-10, PVA-11, and PVA-12 was visually observed by measuring the change in the size of the light spot after covering a blue laser diode (200mW, 450nm, LED). Photographs of the light spots were taken with blue LED, blue LED + pure PVA film, and blue LED + PVA-9, PVA-10, PVA-11, and PVA-12 (1.0wt%) to test the blue light shielding capabilities of PVA-9, PVA-10, PVA-11, and PVA-12. Figure 10 As shown, after covering with pure PVA film, the size of the light spot and the intensity of transmitted blue light are similar to those of bare blue LEDs. However, when covered with blue LED + PVA-11 or PVA-12 (1.0 wt%), the size of the light spot and the intensity of transmitted blue light are significantly reduced, indicating that PVA-11 and PVA-12 have excellent blue light blocking capabilities.

[0136] Example 9: Protective effect of various PVA films of the present invention on ARPE-19 cells under blue light irradiation.

[0137] To further understand the blue light blocking ability of the obtained PVA membrane, ARPE-19 cells were divided into three groups: a dark group (cultured normally in darkness), a blue light group (directly exposed to a blue light source), and a third group (with a PVA membrane placed between the blue light source and the cells). The LED light source used for blue light irradiation of ARPE-19 cells had a peak wavelength of 452 nm and an irradiance of 1.08 mW·cm⁻¹. -2 Incubate for 4 hours, repeat 3 times (Table 3). Figure 11 ).

[0138] Depend on Figure 11 As shown in Table 4, the blue light group data indicates that this light source has high phototoxicity to human retinal epithelial cells ARPE-19, with a cell survival rate of 44.17%. After covering with PVA-11 or PVA-12, the survival rate of ARPE-19 cells increased to 85.68% and 65.73%, respectively, indicating that PVA-11 and PVA-22 films can greatly reduce the damage of blue light to ARPE-19 cells and have a high protective ability for ARPE-19 cells.

[0139] Changes in cell morphology were observed under an optical microscope. Figure 12 As can be seen, in the dark group without blue light irradiation, ARPE-19 cells were mainly spindle-shaped; after 4 hours of blue light irradiation, the morphology of ARPE-19 cells in the control group changed significantly, all becoming spherical; after covering with PVA-11 and PVA-12, the cell morphology did not change significantly and still showed a spindle shape, indicating that PVA-11 and PVA-12 can block short-wavelength blue light and reduce morphological abnormalities of cells.

[0140] Table 3. Protective effects of PVA-11 and PVA-12 on ARPE-19 cells

[0141]

[0142] Example 10: Dark toxicity and phototoxicity of first derivative 9, second derivative 10, third derivative 12 and fifth intermediate 11

[0143] The dark toxicity and phototoxicity of the compound on human liver immortalized cells (THLE-2) were detected using the MTT assay. After the test samples were prepared, THLE-2 cells were seeded into 96-well plates, and different concentrations of the compound were added. After incubation for 48 hours, the cells were irradiated with a photodynamic therapy device with a light source of 452 nm. The control group was not irradiated. Figure 13 As shown in Table 4, THLE-2 cells treated with derivative 9, derivative 10, intermediate 11, and derivative 12 exhibited high survival rates under both dark and light conditions, indicating that derivatives 9, 10, 11, and 12...

[0144] It exhibits negligible phototoxicity and dark toxicity, suggesting that it can be used as a sunscreen agent in subsequent mouse experiments.

[0145] Table 4. Half-maximal inhibitory effects (IC50) of first derivative 9, second derivative 10, third derivative 12, and fifth intermediate 11 on THLE-2 cells. 50 )

[0146]

[0147] Example 11: Cost Comparison of PVA-11, PVA-12, and Commercially Available Anti-Blue Films

[0148] As shown in Table 5, taking PVA-12 as an example, 10×10 cm 2 An anti-blue light film with a content of 1.0 wt% and a blue light blocking rate of over 90% costs 0.52 yuan, while a commercially available anti-blue light film under the same conditions costs 20.5 yuan. The PVA film synthesized in this paper is far cheaper than commercially available anti-blue light films and has broad application and development prospects.

[0149] Table 5 Synthesis costs of PVA-11 and PVA-12 (size: 10*10cm) 2 )

[0150]

[0151] The manufacturer did not disclose the membrane composition and content.

Claims

1. A method for preparing a class of anti-blue light film based on TB-thiophene malononitrile derivatives, characterized in that, The preparation method includes: Step 1: 4-Bromoaniline (1) or 2-methoxy-4-bromoaniline (4) reacts with paraformaldehyde (2) to obtain the first intermediate (3) or the second intermediate (5), as shown in the following reaction formula: Step 2: The first intermediate (3) or the second intermediate (5) reacts with n-butyllithium to obtain the third intermediate (6) or the fourth intermediate (7), respectively, as shown in the following reaction formula: Step 3: The third intermediate (6) or the fourth intermediate (7) reacts with 5-bromothiophene-2-carboxaldehyde (8) to obtain the first derivative (9) or the second derivative (10), as shown in the following reaction formula: Step 4, the first derivative (9) or the second derivative (10) reacts with malononitrile to obtain the fifth intermediate (11) or the second intermediate (10). The reaction formula for the tri-derivative (12) is as follows: The first derivative (9), the second derivative (10), the third derivative (12) or the fifth intermediate (11) are doped into polyvinyl alcohol (PVA) to prepare the corresponding films PVA-9, PVA-10, PVA-11 and PVA-12.

2. The preparation method of the TB-thiophene malononitrile derivative-based anti-blue light film according to claim 1, characterized by, The polyvinyl alcohol (PVA) has a relative molecular mass MW = 3000 g / mol.

3. The preparation method of the TB-thiophene malononitrile derivative-based anti-blue light film according to claim 1, characterized by, The prepared PVA films include three types: PVA-9 (0.1 wt%, 0.5 wt%, and 1.0 wt%), PVA-10 (0.1 wt%, 0.5 wt%, and 1.0 wt%), PVA-11 (0.1 wt%, 0.5 wt%, and 1.0 wt%), and PVA-12 (0.1 wt%, 0.5 wt%, and 1.0 wt%).

4. An application of a type of anti-blue light film based on a TB-thiophene malononitrile derivative prepared by the method of claim 1, characterized in that, The application of the aforementioned thin films PVA-9, PVA-10, PVA-11, and PVA-12 in shielding blue light.

5. An application of a blue light blocking film based on a TB-thiophene malononitrile derivative prepared by the method of claim 1, characterized in that, Applications of the aforementioned thin films PVA-9, PVA-10, PVA-11, and PVA-12 in visible light transmission.

6. An application of a type of anti-blue light film based on a TB-thiophene malononitrile derivative prepared by the method of claim 1, characterized in that, The application of the aforementioned films PVA-9, PVA-10, PVA-11, and PVA-12 in protecting human retinal pigment epithelial cells ARPE-19.

Citation Information

Patent Citations

  • Phenoxazine aldehyde group derivative as well as preparation method and application thereof

    CN114560823A

  • Nitrogen-containing fused ring derivative, pharmaceutical composition, and preparation method and application of nitrogen-containing fused ring derivative

    CN115232144A